Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 075 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 075 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose 5% provides free water and calories for cellular metabolism, with glucose being the primary energy source. Sodium chloride 0.33% restores sodium and chloride ions to maintain extracellular fluid osmolality and acid-base balance. Potassium chloride 0.075% replenishes potassium, essential for nerve conduction, muscle contraction, and enzymatic reactions.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion. Dose determined by fluid, electrolyte, and caloric requirements. Typical adult dose: 500-1000 mL as a single infusion at a rate of 100-200 mL/hour, based on clinical status.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Dextrose: <15 minutes (rapid cellular uptake and metabolism). Electrolytes: sodium and chloride have no defined half-life due to rapid distribution and renal regulation; potassium half-life approximately 1-1.5 hours in plasma following intravenous administration.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Dextrose: nearly completely metabolized to CO2 and water, with <1% excreted unchanged in urine. Sodium and chloride: primarily excreted renally, with >90% of filtered load reabsorbed; excretion varies with dietary intake and homeostatic mechanisms. Potassium: >90% excreted renally, with the remainder in feces and sweat.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte